BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33501563)

  • 1. ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial.
    de Albuquerque Coelho SC; Giraldo PC; Brito LGO; Juliato CRT
    Int Urogynecol J; 2021 Jun; 32(6):1571-1578. PubMed ID: 33501563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial.
    Chiengthong K; Ruanphoo P; Chatsuwan T; Bunyavejchevin S
    Int Urogynecol J; 2022 Jul; 33(7):1833-1838. PubMed ID: 33991221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
    Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
    Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
    Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
    J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
    Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
    Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: ESTROgen use on complications for women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial.
    Dubinskaya A
    Int Urogynecol J; 2021 Jun; 32(6):1605. PubMed ID: 33609162
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.
    Shayo BC; Masenga GG; Rasch V
    Int Urogynecol J; 2019 Aug; 30(8):1313-1321. PubMed ID: 30121703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing internal and external pessaries in the treatment of pelvic organ prolapse in postmenopausal women: A pilot study.
    Hosoume RS; Peterson TV; Soares Júnior JM; Baracat EC; Haddad JM
    Clinics (Sao Paulo); 2024; 79():100335. PubMed ID: 38484583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
    Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
    J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
    Dueñas JL; Miceli A
    Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.
    Lone F; Thakar R; Sultan AH
    Int Urogynecol J; 2015 Sep; 26(9):1305-12. PubMed ID: 25862241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative interventions in pelvic organ prolapse surgery.
    Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
    Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
    Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vaginal estrogen on pessary use.
    Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
    Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse.
    Abdool Z; Thakar R; Sultan AH; Oliver RS
    Int Urogynecol J; 2011 Mar; 22(3):273-8. PubMed ID: 21161179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ring pessaries versus vaginal hysterectomy for advanced pelvic organ prolapse. A cohort study.
    Miceli A; Dueñas-Diez JL
    Int Urogynecol J; 2019 Dec; 30(12):2161-2169. PubMed ID: 30863947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis.
    Ai F; Wang Y; Wang J; Zhou L; Wang S
    Climacteric; 2022 Dec; 25(6):533-542. PubMed ID: 35695119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Prolapse and Urinary Symptoms After Successful Fitting of a Ring Pessary With Support in Women With Advanced Pelvic Organ Prolapse: A Prospective Study.
    Ding J; Chen C; Song XC; Zhang L; Deng M; Zhu L
    Urology; 2016 Jan; 87():70-5. PubMed ID: 26375847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
    Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.